Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page's revision label changed from v3.6.4 to v3.6.5, signaling a small update to the Study Details page.SummaryDifference0.0%

- Check15 days agoChange DetectedThe study record now includes an EU CTIS trial number (2024-514479-16-00) and recent update dates, representing regulatory identifiers and the latest data refresh for the record.SummaryDifference0.2%

- Check22 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a minor software version update on the page.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page’s Revision identifier was updated from v3.6.2 to v3.6.3, reflecting a newer version of the page. This appears to be an internal versioning update rather than a change to the study details or user-facing content.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2. This reflects a newer patch level of the document rather than content changes.SummaryDifference0.0%

- Check65 days agoChange DetectedRecruitment status on the study page now indicates enrollment is closed. The page also adds new help and navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision label to v3.6.0, with a minor formatting change to the Intervention/Treatment header.SummaryDifference0.3%

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.